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Abstract
Background and Purpose: Considering the potential impact of warm ischemia time (WIT) on renal functional
outcomes after robot-assisted partial nephrectomy (RAPN), many techniques that reduce or eliminate WIT have
been studied. We present our institutional experience and progression using one such technique—off-clamp
RAPN—as well as the results of this technique in the management of complex cases.
Patients and Methods: A retrospective chart review of 65 patients undergoing off-clamp RAPN was performed, 15
of whom underwent off-clamp RAPN for 26 complex tumors. Complex features included hilar location, completely
endophytic growth, and ipsilateral multifocality. In all cases, hilar vessels were dissected but not clamped.
Results: Mean tumor size was 2.5 cm (standard deviation; [SD] = 1.4), while mean nephrometry score was 8.7
(SD = 1.5). One (7%) intraoperative complication occurred. Mean estimated blood loss was 403 mL (SD = 381),
mean operative time was 190 minutes (SD = 68), and WIT was 0 minutes in all cases. Mean length of stay was 1.8
days (SD = 0.9), with one patient needing a postoperative blood transfusion (Clavien II complication). Final
pathology results demonstrated clear-cell carcinoma (n = 16), papillary carcinoma (n = 4), angiomyolipoma
(n = 1), oncocytoma (n = 2), and cystic nephroma (n = 3). Margins were negative for tumor for 96% (25/26) of
resected masses. Estimated glomerular filtration rate (eGFR) decreased by an average of 3.1 mL/min/1.73m2
(SD = 9.8, P = 0.24), at a mean follow-up of 177 days (SD = 296). Five patients with radiographic follow-up of at
least 6 months have no evidence of disease recurrence.
Conclusions: Off-clamp RAPN can be safely and effectively performed even in the case of complex tumors, but
occurs with higher estimated blood loss. Minimal changes in eGFR were experienced by patients undergoing off-
clamp RAPN at an average follow-up of roughly 6 months. Longer follow-up and direct comparison with
conventional clamped RAPN technique are needed to establish the efficacy of off-clamp RAPN in complex cases.
Introduction
With evidence demonstrating improved survivalafter partial rather than radical nephrectomy, nephron-
sparing surgery (NSS) has become the standard of care for the
management of T1a renal tumors.
1 With continued technologic
technological advances by the urologic community, laparo-
scopic partial nephrectomy (LPN) and, more recently, robot-
assisted partial nephrectomy (RAPN) have been established
as viable alternatives to open partial nephrectomy.2,3
Renal hilar clamping during minimally invasive NSS is
typically performed under warm ischemia conditions. Re-
cognizing the importance of limiting warm ischemia time
(WIT) on potential preservation of long-term renal function,4–6
various surgical techniques that reduce or eliminate WIT have
been described.7–13
Over the last 5 years, our institution has performed RAPN
without clamping of the renal hilum in selected patients. As
our experience has grown, we have applied this technique to
increasingly challenging cases. We present our institutional
trends regarding off-clamp RAPN and highlight our experi-
ence with this technique in the management of complex renal
tumors.
Patients and Methods
Retrospective chart review was performed with Institu-
tional Review Board approval. A total of 65 cases of off-clamp
RAPN for suspected renal-cell carcinoma (RCC) were identi-
fied between August 2007 and May 2012. Among these pa-
tients, 15 underwent off-clamp RAPN for 26 ‘‘complex
tumors’’ between January 2009 and May 2012. Complex tu-
mors were defined as those with hilar location, completely
endophytic growth, and/or multiple ipsilateral masses, fol-
lowing the same criteria as in previously published stud-
ies.14,15 Preoperative CT or MRI demonstrated enhancing
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renal masses that were suspicious for RCC in all patients.
Treatment options were discussed with patients, and selection
of off-clamp RAPN was based on tumor size, tumor location,
patient comorbidities, and surgeon and patient preference.
One patient had known von-Hippel-Lindau syndrome and
had undergone previous renal surgery consisting of laparo-
scopic cryoablation of tumors in the contralateral kidney. No
other patients had previous renal surgery.
Surgical technique
In general, RAPN was performed using a transperitoneal
approach for anterior tumors and a retroperitoneal approach
for posterior tumors. The kidney was mobilized, and peri-
nephric fat overlying the tumor was excised. As a precaution,
the renal hilum was exposed, and bulldog clamps were placed
in the surgical field to enable prompt vascular control. Of
note, the renal hilar dissection included only the main renal
vessels; no segmental arteries were dissected. No hilar, seg-
mental, or selective arterial occlusion was performed. Tumor
depth was assessed with the aid of intraoperative robotic
ultrasonography (Aloka, Wallingford, CT), in conjunction
with the da Vinci Surgical System TilePro feature (Intuitive,
Sunnyvale, CA).
With monopolar electrocautery set to 35 W, the resection
site was demarcated circumferentially and tumor excision
was performed. Tumor excision was started nearest to the
largest vessels, and the mass was mobilized away, presum-
ably leading to diminished tumor perfusion as excision pro-
gressed. As the plane of dissection was advanced, the
resection base was meticulously cauterized to ensure hemo-
stasis. If during resection vessels were seen directly entering
the tumor from the resection bed, they were selectively clip-
ped with Weck Hem-o-lok clips (Teleflex, Research Triangle
Park, NC). In addition, if large vessels within the resection bed
remained patent despite electrocautery, then the resection bed
vessel was temporarily occluded using the Prograsp forceps
(Intuitive, Sunnyvale, CA), followed by direct application of
the robotic bulldog clamp to the resection bed.
Once tumor resection was completed, the patent vessels
within the resection bed were identified and ligated with 2-0
polyglactin or Weck Hem-o-lok clips. If the collecting system
was entered, repair was performed with a running 2-0 poly-
glactin suture, which was secured with intracorporeal knots.
Reapproximation of the renal parenchyma was performed
using the sliding-clip renorrhaphy technique.16 Hemostasis of
the resection bed was carefully assessed by decreasing the
insufflation pressure to 5 mm Hg. In a few instances where
slow venous bleeding continued, Floseal (BioSurgery, Deer-
field, IL) and/or Surgicel Nu-knit (Ethicon, Cincinnati, OH)
were applied to enhance hemostasis. Tumors were extracted
with an Endo Catch specimen bag (Covidien, Mansfield,
MA). The gross margins of the tumor were inspected intra-
operatively, and then the specimen was sent for permanent
section.
Data collection and analysis
Patient demographics, tumor characteristics, perioperative
information, and postoperative serum creatinine level were
recorded. Baseline comorbidities were assessed using the
American Society of Anesthesiologists (ASA) classification
and the Charlson Comorbidity Index (CCI).17,18 Nephrometry
score was calculated for all tumors.19 Nephrometry scores of 4
to 6 were considered low, 7 to 9 were considered mid, and 10
to 12 were considered high. Estimated glomerular filtration
rate (eGFR) was calculated using the Chronic Kidney Disease
Epidemiology Collaboration formula.20 Postoperative com-
plications were recorded and classified by Clavien-Dindo
grade.21 The t test was used to compare pre- and postopera-
tive eGFR. Statistical analysis was performed using Quick-
Calcs (GraphPad Software, La Jolla, CA).
Results
A summary of off-clamp RAPN cases performed at our
institution by year and organized by nephrometry score is
provided in Table 1.
The tumor features associated with each complex case are
summarized in Table 2. Preoperative imaging of representa-
tive complex off-clamp RAPN cases are provided in Figure 1.
Patient and tumor characteristics for complex and non-
complex cases are summarized in Table 3. For the com-
plex cases: Mean patient age was 59 years ([SD]= 11, range
37–73), mean ASA classification was 2.5 (SD= 0.6), mean
CCI was 2.4 (SD = 1.1), mean preoperative eGFR was
Table 1. Summary of Off-Clamp Robot-Assisted Par-
tial Nephrectomy Cases Performed






















2007 2 8% 2 0 0 0
2008 5 6% 4 0 1 0
2009 5 5% 4 1 0 1
2010 5 4% 4 1 0 0
2011 21 13% 9 10 2 7
2012a 27 33% 9 16 2 7
RAPN= robot-assisted partial nephrectomy; neph.=nephrometry.
aYear to date ( January to May 2012).









2009 1 1 1 0
2011 2 1 1 0
3 1 0 1
4 8 1 2
5 1 1 0
6 2 1 0
7 1 1 0
8 1 0 1
2012 9 1 0 1
10 3 1 0
11 2 0 0
12 1 0 1
13 1 0 1
14 1 1 1
15 1 1 1
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81.8 mL/min/1.73 m2 (SD = 25.3, range 23.8–128), mean
tumor size was 2.5 cm (SD= 1.4, range 0.8–5.5), and mean
nephrometry score was 8.7 (SD = 1.5, range 6–11).
Perioperative, functional, and oncologic outcomes for
complex and noncomplex cases are summarized in Table 4.
WIT was 0 minutes in all cases. For the complex cases: Mean
operative time was 190 minutes (SD = 68, range 106–353),
mean estimated blood loss (EBL) was 403 mL (SD= 381, range
50–1500), intraoperative complication rate was 7% (1/15),
mean hospital stay was 1.8 days (SD = 0.9, range 1–4), post-
operative complication rate was 7% (1/15), and surgical
margins were negative in 25/26 (96%) tumors. The intra-
operative complication consisted of a patient going into atrial
fibrillation near the end of the case. She had a known history
of intermittent atrial fibrillation. She was taken to the inten-
sive care unit on completion of the case, medically converted
to sinus rhythm, and discharged after 2 days. The postoper-
ative complication consisted of a patient with eight ipsilateral
masses (EBL = 1500 mL) necessitating a postoperative blood
transfusion (Clavien II).
Mean postoperative eGFR was 78.6 mL/min/1.73 m2
(SD= 22.6, range 22.8–121) at a mean follow-up of 177 days
(SD= 296, range 1–1157) for the complex cases and was
75.4 mL/min/1.73 m2 (SD = 27.6, range 8.2–131) at a mean
follow-up of 259 (SD = 302, range 1–1007) for the noncomplex
cases. In both the complex and noncomplex groups, the mean
change in eGFR represented a statistically insignificant decline
(complex mean DeGFR= -3.1 mL/min/1.73 m2, P= 0.24; non-
complex mean DeGFR= -2.0 mL/min/1.73 m2, P=0.17). Of
patients with greater than a 6-month radiographic follow-up,
none has evidence of recurrence or metastatic disease (0/27),
with mean follow-up of 355 days (SD=298, range 191–887) for
the complex cases and 492 days (SD=248, range 202–921) for
the noncomplex cases.
Discussion
The adoption of robotic technology in the treatment of
patients with renal tumors has helped surgeons overcome
many technical limitations of LPN, facilitating wider use of
minimally invasive NSS.22 Without compromising oncologic
control, RAPN has demonstrated shorter WIT compared with
traditional LPN.3 Nevertheless, because of the potential im-
pact of even limited WIT on the preservation of long-term
renal function,23 methods to further diminish or eliminate
WIT have been under investigation.8–13
FIG. 1. The above images represent complex robot-
assisted partial nephrectomy cases performed using the
off-clamp technique. (a) Preoperative CT depicting a large,
anterior, hilar renal mass; (b) preoperative MRI depicting
two ipsilateral renal masses; (c) preoperative MRI depicting
an anterior, completely endophytic renal mass. CT = com-
puted tomography; MRI=magnetic resonance imaging.
Table 3. Patient and Tumor Characteristics
for Complex and Non-Complex Cases
Patient characteristics Complex Noncomplex
Number of patients 15 50
Male (%) 7 (47%) 30 (60%)
Female (%) 8 (53%) 20 (40%)
Mean age, years
(SD; range)
59 (11; 37–73) 60 (11; 33–80)
Mean BMI, kg/m2
(SD; range)
30 (6.0; 21–40) 32 (7.8; 19–65)
Mean ASA score (SD) 2.5 (0.6) 2.3 (0.7)
Mean CCI (SD) 2.4 (1.1) 2.5 (1.2)
Mean preoperative
eGFR, mL/min/






Number of tumors 26 50
Left-sided (%) 7 (27%) 31 (62%)
Right-sided (%) 19 (73%) 19 (38%)
Mean tumor size,
cm (SD; range)
2.5 (1.4; 0.8–5.5) 2.6 (1.4; 0.8–8.0)
Mean nephrometry
score (SD; range)
8.7 (1.5; 6–11) 5.9 (1.6; 4–10)
SD = standard deviation; BMI= body mass index; ASA =American
Society of Anesthesiologists; CCI=Charlson Comorbidity Index;
eGFR= estimated glomerular filtration rate.
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As our experience with off-clamp RAPN has grown, we
have used this technique in an increasing number of cases and
increasingly challenging tumors. During 2007 to 2010, off-
clamp RAPN was selectively applied at our institution—two
in 2007, five in each year 2008 to 2010—comprising less than
10% of the total RAPN volume. In addition, during this time
period, most off-clamp RAPN cases involved tumors with a
low nephrometry score (82%). In 2011, a total of 21 off-clamp
RAPN cases were performed, accounting for 13% of the total
RAPN volume at our institution. Of the off-clamp RAPN
cases, 57% (12/21) had mid or high nephrometry scores, and
33% (7/21) involved tumors with complex features. In 2012, a
total of 27 off-clamp RAPN cases have been performed to date
( January to May), accounting for 33% of the total RAPN
volume at our institution. Of the off-clamp RAPN cases, 67%
(18/27) had mid or high nephrometry scores, and 26% (7/27)
involved tumors with complex features.
Although consensus definitions for tumor complexity
continue to evolve,19,24,25 we have used criteria found in
previously published studies.14,15 Endophytic growth, hilar
location, and multifocal ipsilateral presentation are ostensibly
challenging for RAPN and furthermore for off-clamp RAPN.
Because these complex cases may represent an obstacle to the
wider application of the off-clamp RAPN technique, we
sought to examine our own results using this technique for
complex tumors.
We expected that the perioperative results of these complex
cases would differ from that of noncomplex cases within our
off-clamp RAPN experience. The mean tumor sizes among our
50 noncomplex cases, however, were very similar to those of
our 15 complex cases: 2.6– 1.4 vs 2.5– 1.4 cm, respectively.
Mean operative time and EBL for noncomplex cases were 149
minutes and 195 mL compared with 190 minutes and 403 mL
for complex cases. Still, this difference did not seemingly affect
the immediate postoperative course of patients, because length
of hospital stay was similar for both groups: 1.8– 0.9 vs 1.9– 1.0
days, respectively. In addition, postoperative complication
rates were similar regardless of case complexity, 7% (1/15) for
complex and 4% (2/50) for noncomplex cases. Furthermore,
mean eGFR decline experienced by the complex group was
not significantly different from the decline experienced by
the noncomplex group (3.1 vs 2.0 mL/min/1.73 m2; P = 0.7).
This comparison, however, may be underpowered to detect
a significant difference between these groups, and the in-
creased eGFR decline in the complex group could be related
to the increased EBL experienced by those patients (403 vs
195 mL).
Comparison of our complex off-clamp experience with that
of others performing traditional clamped RAPN for complex
tumors may elucidate the major benefits and drawbacks to
performing RAPN without hilar clamping in complex cases.
Both Gong and associates14 and Rogers and colleagues15
Table 4. Perioperative, Functional, and Oncologic Outcomes of Complex and Noncomplex Cases
Perioperative outcomes Complex Noncomplex
Mean operative time, min (SD; range) 190 (68; 106–353) 149 (56; 59–297)
Mean warm ischemia time, min (SD) 0 (0) 0 (0)
Mean estimated blood loss, mL (SD; range) 403 (381; 50–1500) 195 (183; 0–800)
Surgical approach
Transperitoneal (%) 5 (33%) 32 (64%)
Retroperitoneal (%) 10 (67%) 18 (36%)
Intraoperative complications (%) 1/15 (7%) 0/50 (0%)
Mean length of stay, days (SD; range) 1.8 (0.9; 1–4) 1.9 (1.0; 1–6)
Postoperative complications (%) 1/15 (7%) 2/50 (4%)
Pathology
Clear-cell RCC (%) 16/26 (62%) 23/50 (46%)
Papillary RCC (%) 4/26 (15%) 10/50 (20%)
Chromophobe RCC (%) 0/26 (0%) 2/50 (4%)
Angiomyolipoma (%) 1/26 (4%) 5/50 (10%)
Oncocytoma (%) 2/26 (8%) 5/50 (10%)
Cystic nephroma (%) 3/26 (12%) 2/50 (4%)
Other (%) 0/26 (0%) 3/50 (6%)
T Stage
T1a (%) 18/26 (69%) 32/50 (64%)
T1b (%) 2/26 (8%) 2/50 (4%)
T2a (%) 0/26 (0%) 1/50 (2%)
Benign (%) 6/26 (23%) 15/50 (30%)
Negative surgical margin (%) 25/26 (96%) 50/50 (100%)
Functional outcomes
Mean postoperative eGFR, mL/min/1.73 m2 (SD; range) 78.6 (22.6; 22.8–121) 75.4 (27.6; 8.2–131)
Mean change in eGFR, mL/min/1.73 m2 (SD; 95% CI; p) - 3.1 (9.8; - 8.1 to 1.9; 0.24) - 2.0 (9.8; - 4.7–0.7; 0.17)
Mean follow-up for eGFR, days (SD; range) 177 (296; 1–1157) 259 (302; 1–1007)
Oncologic outcomes
Radiographic evidence of recurrence or metastases* 0/5 0/22
Mean radiographic follow-up, days (SD; range)* 355 (298; 191–887) 492 (248; 202–921)
SD= standard deviation, RCC= renal-cell carcinoma, eGFR= estimated glomerular filtration rate.
*=Among patients with imaging follow-up of at least 6 months.
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report on their experience with traditional clamped RAPN for
complex tumors. Mean operative times and EBL reported by
Gong and associates14 and Rogers and colleagues15 were 197
and 192 minutes, 220 and 230 mL, respectively. Our experi-
ence with off-clamp RAPN for complex tumors demonstrates
similar mean operative time (190 min) but substantially
higher mean EBL (403 mL), which is to be expected with no
occlusion of the renal hilum during resection. Importantly,
despite the increased blood loss in our off-clamp series, only
one (7%) patient needed a blood transfusion postoperatively.
The mean declines in eGFR reported by Gong and associates14
and Rogers and colleagues15 were 4.5 and 5.6 mL/min/
1.73 m2, respectively. The mean decline in eGFR after off-
clamp RAPN in our series was 3.1 mL/min/1.73 m2, which
may not represent a clinically or statistically significant
difference.
Another difference between our series and that of Gong
and associates14 and Rogers and colleagues15 was the positive
surgical margin rate. All surgical margins were negative
in their studies, using traditional clamped RAPN for com-
plex tumors. The present study of off-clamp RAPN for
complex tumors, however, had negative surgical margins in
25 of 26 tumors. The positive surgical margin occurred in the
smallest tumor of the patient undergoing resection of three
ipsilateral masses (2.1, 1.5, and 0.8 cm), which were found to
be papillary RCC. The boundaries of the tumor were ade-
quately visualized with intraoperative ultrasonography at
the time of resection. After tumor excision, the resection
bed was carefully examined, appeared to be free of tumor,
and was thoroughly fulgurated. On extraction, the specimen
was sectioned by pathology associates in the operating
room, which grossly showed that the tumor was confined to
its pseudocapsule; however, final pathology results dem-
onstrated tumor abutting the inked margin. Studies have
suggested that after LPN, positive surgical margins are not
always indicative of residual disease.26 The patient has
elected monitoring, and cross-sectional imaging will be
performed in 6 months.
Because many of our complex off-clamp RAPN cases were
performed recently, oncologic outcomes are not yet mature in
all of our patients. Five of the 15 patients have greater than
6-month follow-up imaging (mean follow-up of 355 days),
and all five patients have no evidence of local tumor recur-
rence or metastatic disease.
Limitations to our study include limited renal functional
follow-up and small sample size. To completely describe our
perioperative outcomes, patients who were very recently
treated with off-clamp RAPN for complex tumors were also
included. Moreover, of our 65 total cases of off-clamp RAPN,
application of this technique to complex tumors has been
relatively recent, as we have continued to gain confidence
with our experience. As a result, the length of renal functional
follow-up for our cohort ranges from 1 to 1157 days. Our strict
definition for tumor complexity as well as the aforementioned
recent application of off-clamp RAPN to complex tumors has
resulted in a small sample size, which may also limit broader
interpretation of our results.
As we continue to gain more experience with off-clamp
RAPN and apply this technique to increasingly complex tu-
mors, larger studies should be performed to better and more
fully determine the impact of tumor complexity on surgical
outcomes. Multi-institutional collaboration to recruit suffi-
cient numbers of patients may also be needed to facilitate
this assessment. Importantly, distinguishing the impact of
the off-clamp technique on perioperative, renal functional,
and oncologic outcomes for complex tumors ideally requires a
prospective, randomized comparison between off-clamp
RAPN and conventional clamped RAPN. Finally, large pro-
spective studies evaluating perioperative outcomes and
complication rates after RAPN for the treatment of increas-
ingly challenging tumors can be used to validate definitions of
complexity.
Conclusions
Off-clamp RAPN for complex tumors resulted in minimal
changes in eGFR at roughly mean 6-month follow-up. All
patients with imaging follow-up greater than 6 months
postoperatively showed no evidence of disease. Perioperative
outcomes were generally similar between our complex and
noncomplex off-clamp RAPN cases, except with greater blood
loss in our complex group. Our results were also comparable
to single institution series reporting outcomes of complex
cases treated with conventional RAPN. Although blood loss is
more substantial in our complex off-clamp RAPN cohort, we
believe with more experience performing the off-clamp tech-
nique, case complexity minimally impacts perioperative and
functional outcomes after off-clamp RAPN.
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